KE-37

Cat.No.: CSC-C0218

Species: Homo sapiens (Human)

Morphology: single, round cells in suspension

Culture Properties: suspension

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C0218
Description
Established from a 27-year-old man with acute lymphoblastic leukemia (ALL) in 1979
Species
Homo sapiens (Human)
Recommended Medium
90-92.5% RPMI-1640 + 7.5-10% h.i. FBS
Culture Properties
suspension
Morphology
single, round cells in suspension
Karyotype
Human flat-moded hypotetraploid karyotype - 91(86-92)<4n>XXYY, +8, -14, -14, t(7;12)(q32-33;p12-13)x2, der(8)t(8;14)(q24;q11)x4, der(14)t(8;14)(q24;q11)x2 - resembles published karyotype - carries 4 copies of der(8)t(8;14) associated with T-ALL - normal c
Disease
Adult T Acute Lymphoblastic Leukemia
Quality Control
Mycoplasma: contamination was eliminated with Baytril (enrofloxacin), then negative in DAPI, microbiological culture, RNA hybridization, PCR assays
Immunology: CD2 +, cyCD3 +, smCD3 -, CD4 +, CD5 +, CD6 +, CD7 +, CD8 +, CD13 -, CD19 -, CD34 -, TCRalpha/b
Storage and Shipping
Frozen with 70% medium, 20% FBS, 10% DMSO at about 8 x 10^6 cells/ampoule; ship in dry ice; store in liquid nitrogen
Synonyms
KE 37; KE37
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

KE-37 is a human cell line derived from peripheral blood of a 27-year-old man in 1979. The human cell line is used as a model system in the study of immunology and hematology. The cell line is known as a T-cell acute lymphoblastic leukemia (T-ALL) cell line. KE-37 has been used as a model to study the molecular pathogenesis of T-cell malignancies and to test the efficacy of new chemotherapeutic agents and immunotherapies.

The KE-37 cell line demonstrates the characteristic of growing in suspension culture conditions. The cells have a round morphology and grow as single cells or small clusters. The cells show an immunophenotype of an immature or intermediate stage T-cell. The cell line is usually positive for CD2, CD4, and CD7 and negative for the mature T-cell receptor complex (CD3-). The cell line often contains a complex karyotype, including the most frequent translocation, t(8;14)(q24;q11), resulting in juxtaposition of the MYC oncogene to the T-cell receptor alpha/delta locus, seen in many cases of T-ALL.

KE-37 has also been at the center of several cell line authentication reports over the past few years. The recently reported widely used cell line SKW-3 has been found to be a derivative of KE-37 as a result of historic cross-contamination. KE-37 is used for high-throughput drug screening, signaling pathway studies (Notch1 or PI3K/AKT for example) and the development of CAR-T and bispecific antibody therapies for T-cell leukemias.

Human Notch-Dependent T-ALL Cell Lines Induce MDSCs From Healthy PBMCs

Notch receptors influence T-cell development, and their dysregulation is linked to T-ALL. MDSCs inhibit immune responses in tumors but are understudied in T-ALL. Here, Grazioli et al. used a Notch3-transgenic murine model of T-ALL to show that Notch-signaling deregulation promotes CD11b+Gr-1+ MDSCs.

They extended their research to humans by coculturing PBMCs from healthy donors with the human Notch-dependent T-ALL cell line KE-37, which has Notch1 oncogenic mutations and is GSI resistant and Notch3 negative. KE-37 cells also express intracellular IL-6. In PBMCs/KE-37 cocultures, there was a significant increase in CD14+HLA-DRlow/neg MDSCs, both in percentage and absolute numbers, compared to PBMCs cultured alone (Fig. 1A, B). The CD33+ cells from these cocultures showed high suppressive function on autologous CD4-CD8+ T cells (Fig. 1C). KE-37 cells, which lack PTEN expression, do not respond to GSI treatment, although GSI blocks Notch1 activation. They confirmed Notch1 intracellular domain expression in KE-37 cells and its downregulation by GSI during cocultures (Fig. 2A). Repeating the coculture experiments with gamma-secretase inhibitors or neutralizing anti-IL-6 antibodies showed significant reductions in MDSC expansion (Fig. 1D, E), indicating that Notch activation and IL-6 signaling are crucial for MDSC expansion in these cocultures.

The Notch1-active T-ALL cell line, KE-37 induces MDSCs from healthy PBMCs.

Fig. 1. The Notch1-active T-ALL cell line, KE-37 induces MDSCs from healthy PBMCs (Grazioli P, Orlando A, et al., 2022).

During the co-cultures with healthy PBMCs, KE-37 cells express IL-6 and down-modulate Notch1-active protein upon GSI treatment.

Fig. 1. During the co-cultures with healthy PBMCs, KE-37 cells express IL-6 and down-modulate Notch1-active protein upon GSI treatment (Grazioli P, Orlando A, et al., 2022).

Ask a Question

Write your own review

  • You May Also Need

For research use only. Not for any other purpose.

Hot Products